Alivus Life Sciences Cash Flow Annual

BSE: - | NSE: - | ISIN: - | Sector: -
885.85 -6.20 (-0.70%)Updated : 11 Dec 2025
Fiscal Period2025202420232022
Period End DateMar 25Mar 24Mar 23Mar 22
Issuance( Retirement)of Debt Net -4.49-2.21-1.13-961.92
Net Changein Cash -230.3517.59-228.33396.56
Cash Taxes Paid 162.95162.96153.57138.17
Net Income/ Starting Line 654.13631.29628.61564.93
Changesin Working Capital -343.33-297.04-367.23-38.33
Cashfrom Operating Activities 391.52413.52306.01597.59
Cash Interest Paid 2.411.550.550.07
Cashfrom Financing Activities -6.23-279.44-387.59-78.80
Issuance( Retirement)of Stock Net 0.67--1,011.85
Depreciation/ Depletion 60.6153.4542.0937.88
Other Investing Cash Flow Items Total -449.4612.4916.059.94
Capital Expenditures -166.19-128.97-162.80-132.17
period Type ----
Non- Cash Items 20.1125.822.5333.11
Financing Cash Flow Items -2.41-1.55-0.55-0.07
period Length 12.0012.0012.0012.00
Cashfrom Investing Activities -615.65-116.48-146.75-122.23
Total Cash Dividends Paid --275.69-385.92-128.65
*All figures in crores except per share values
Recommended For You
Trending Stocks
290.85+7.50(2.65%)
166.35+4.15(2.56%)
2,175.45+46.15(2.17%)
2,778.50-26.15 (-0.93%)
2,052.40-14.30 (-0.69%)